Revised version approved by the Board of Directors on January 11, 2014.
Goal 1: ASTRO will provide state-of-the-art education and lifelong professional development in the effective use of radiation as a tool for the treatment of patients with cancer and benign disease.
- ASTRO will be the primary source for the educational needs of radiation oncology and will continue to organize the world’s leading radiation oncology scientific meeting.
- ASTRO will support continuous certification by increasing the number of available online/live SAMS and encouraging member participation as a critical component of maintaining clinical skills.
- ASTRO will continue the support and development of small meetings as appropriate for the needs of the specialty.
- ASTRO will continue to provide educational resources for all radiation oncology trainees and interested medical students.
- ASTRO will work with radiation oncology societies globally to coordinate educational opportunities.
Goal 2: ASTRO will publish the premier scientific and practice journals in radiation oncology.
- ASTRO will continue to publish the leading scientific journal in the field, the International Journal of Radiation Oncology•Biology•Physics (IJROBP/Red Journal).
- ASTRO will continue to expand Practical Radiation Oncology (PRO).
Goal 3: ASTRO will advance the science through research and innovation to improve clinical outcomes for each patient.
- ASTRO will promote advances in research to raise the profile of the specialty.
- ASTRO will support the development of comparative effectiveness research on the value of radiation oncology.
- ASTRO will build a substantive, collaborative and public relationship with cooperative clinical trial networks (RTOG/NRG Oncology, Alliance, ECOG/ACRIN, SWOG) and will work closely with federal programs supporting cancer research including the NCI.
- ASTRO will continue to provide opportunities for basic, translational and clinical research scientists.
Goal 4: ASTRO will be the premier voice for advocacy and health policy for radiation oncology.
- ASTRO will continue to be the premier voice in Congress on critical policy issues concerning the specialty and support ASTRO members in state advocacy.
- ASTRO will continue to be the premier organization representing radiation oncology before government agencies, AMA and third party payers.
- ASTRO will lead efforts to focus on scope of practice and responsible health care resource utilization to promote patient-centered care.
- ASTRO will take a leadership position on exploring payment reform initiatives and innovative payment models for radiation oncology.
- ASTRO will continue educational outreach activities to the public, referring physicians and the media.
- ASTRO will advance the education of members on the impact of health policy issues on the specialty.
Goal 5: ASTRO will shape the framework for the delivery of safe, high-quality, high-value health care to all patients (cancer, benign disease) by the radiation oncology team.
- ASTRO will create a robust set of clinical practice statements/guidelines.
- ASTRO will support plans for the design, funding and implementation of a national data registry for radiation oncology.
- ASTRO will make recommendations to improve patient safety and to mitigate the potential for error in the radiation therapy planning and delivery process.
- ASTRO will expand and improve our Practice Accreditation Program.
- ASTRO will develop measures-based programs for the assessment and improvement of patient care and safety.
- ASTRO will continually update standards for the training, experience and team composition necessary to perform advanced technology.
- ASTRO will continue to develop the IHE-RO program, setting standards for the interchangeable use of common technologies.